NASDAQ:NATRNature's Sunshine Products Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Nature's Sunshine Products Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $10.99 -0.30 (-2.66 %) (As of 08/14/2020 04:00 PM ET) Add Compare Share Today's Range$10.95Now: $10.99▼$11.4250-Day Range$7.93MA: $9.61▼$11.1252-Week Range$5.50Now: $10.99▼$11.72Volume21,564 shsAverage Volume27,978 shsMarket Capitalization$214.43 millionP/E Ratio19.63Dividend YieldN/ABeta0.72 ProfileChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Nature's Sunshine Products, Inc., a natural health and wellness company, primarily engages in the manufacture and sale of nutritional and personal care products worldwide. It operates through four segments: NSP Americas; NSP Russia; Central and Eastern Europe; and NSP China. The company offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. It also provides immunity, cardiovascular, and digestive products; and personal care products, including oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpastes, and skin cleansers, as well as weight management products. The company offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent managers and distributors. Nature's Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Nature's Sunshine Products. Previous Next 2.3 Community Rank Outperform VotesNature's Sunshine Products has received 147 “outperform” votes. (Add your “outperform” vote.)Underperform VotesNature's Sunshine Products has received 176 “underperform” votes. (Add your “underperform” vote.)Community SentimentNature's Sunshine Products has received 54.49% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Nature's Sunshine Products and other stocks. Vote “Outperform” if you believe NATR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NATR will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldNature's Sunshine Products does not currently pay a dividend.Dividend GrowthNature's Sunshine Products does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Nature's Sunshine Products insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,750,000.00 in company stock.Percentage Held by InsidersOnly 16.00% of the stock of Nature's Sunshine Products is held by insiders.Percentage Held by Institutions77.64% of the stock of Nature's Sunshine Products is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Nature's Sunshine Products is 19.63, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 17.39.Price to Earnings Ratio vs. SectorThe P/E ratio of Nature's Sunshine Products is 19.63, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.15.Price to Book Value per Share RatioNature's Sunshine Products has a P/B Ratio of 1.64. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.79 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Pharmaceutical preparations Sub-IndustryPersonal Products SectorMedical Current SymbolNASDAQ:NATR Previous Symbol CUSIP63902710 CIK275053 Webwww.naturessunshine.com Phone801-341-7900Debt Debt-to-Equity Ratio0.14 Current Ratio2.02 Quick Ratio1.26Price-To-Earnings Trailing P/E Ratio19.63 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$362.21 million Price / Sales0.59 Cash Flow$1.00 per share Price / Cash Flow11.00 Book Value$6.70 per share Price / Book1.64Profitability EPS (Most Recent Fiscal Year)N/A Net Income$6.76 million Net Margins3.04% Return on Equity8.03% Return on Assets4.85%Miscellaneous Employees905 Outstanding Shares19,511,000Market Cap$214.43 million Next Earnings Date11/5/2020 (Estimated) OptionableNot Optionable $10.99 -0.30 (-2.66 %) (As of 08/14/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive NATR News and Ratings via Email Sign-up to receive the latest news and ratings for NATR and its competitors with MarketBeat's FREE daily newsletter. Nature's Sunshine Products (NASDAQ:NATR) Frequently Asked Questions How has Nature's Sunshine Products' stock been impacted by COVID-19? Nature's Sunshine Products' stock was trading at $7.79 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, NATR stock has increased by 41.1% and is now trading at $10.99. View which stocks have been most impacted by COVID-19. When is Nature's Sunshine Products' next earnings date? Nature's Sunshine Products is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020. View our earnings forecast for Nature's Sunshine Products. How were Nature's Sunshine Products' earnings last quarter? Nature's Sunshine Products (NASDAQ:NATR) announced its earnings results on Tuesday, August, 7th. The company reported ($0.08) earnings per share (EPS) for the quarter. The company had revenue of $91.27 million for the quarter. Nature's Sunshine Products had a return on equity of 8.03% and a net margin of 3.04%. View Nature's Sunshine Products' earnings history. Has Nature's Sunshine Products been receiving favorable news coverage? Media headlines about NATR stock have trended somewhat positive on Saturday, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Nature's Sunshine Products earned a coverage optimism score of 0.6 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news about Nature's Sunshine Products. Are investors shorting Nature's Sunshine Products? Nature's Sunshine Products saw a increase in short interest in June. As of June 30th, there was short interest totaling 99,600 shares, an increase of 23.0% from the June 15th total of 81,000 shares. Based on an average trading volume of 39,200 shares, the short-interest ratio is presently 2.5 days. Approximately 0.7% of the shares of the stock are sold short. View Nature's Sunshine Products' Short Interest. Who are some of Nature's Sunshine Products' key competitors? Some companies that are related to Nature's Sunshine Products include Estee Lauder Companies (EL), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), Medifast (MED), Prestige Consumer Healthcare (PBH), USANA Health Sciences (USNA), Inter Parfums (IPAR), Revlon (REV) and Veru (VERU). View all competitors. What other stocks do shareholders of Nature's Sunshine Products own? Based on aggregate information from My MarketBeat watchlists, some companies that other Nature's Sunshine Products investors own include Amicus Therapeutics (FOLD), Gilead Sciences (GILD), AT&T (T), AbbVie (ABBV), Akorn (AKRX), Bausch Health Companies (BHC), Chesapeake Energy (CHKAQ), Chesapeake Energy (CHKAQ), Catalyst Pharmaceuticals (CPRX) and Pfizer (PFE). Who are Nature's Sunshine Products' key executives? Nature's Sunshine Products' management team includes the following people: Mr. Terrence O. Moorehead, Pres, CEO & Director (Age 56)Mr. Joseph W. Baty, Exec. VP, CFO & Treasurer (Age 62)Ms. Susan M. Armstrong, Exec. VP & COO (Age 54)Ms. Adriana G. Mendizábal, Chief Marketing OfficerMr. Nathan G. Brower, Exec. VP, Gen. Counsel & Sec. (Age 39) What is Nature's Sunshine Products' stock symbol? Nature's Sunshine Products trades on the NASDAQ under the ticker symbol "NATR." Who are Nature's Sunshine Products' major shareholders? Nature's Sunshine Products' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Red Mountain Capital Partners LLC (12.93%), Prescott Group Capital Management L.L.C. (7.69%), Russell Investments Group Ltd. (0.20%) and UBS Group AG (0.02%). Company insiders that own Nature's Sunshine Products stock include Kristine F Hughes, Prescott Group Capital Managem and Wynnefield Partners Small Cap. View institutional ownership trends for Nature's Sunshine Products. Which institutional investors are selling Nature's Sunshine Products stock? NATR stock was sold by a variety of institutional investors in the last quarter, including Prescott Group Capital Management L.L.C., Russell Investments Group Ltd., and UBS Group AG. Company insiders that have sold Nature's Sunshine Products company stock in the last year include Kristine F Hughes, and Prescott Group Capital Managem. View insider buying and selling activity for Nature's Sunshine Products. Which institutional investors are buying Nature's Sunshine Products stock? NATR stock was purchased by a variety of institutional investors in the last quarter, including Red Mountain Capital Partners LLC. View insider buying and selling activity for Nature's Sunshine Products. How do I buy shares of Nature's Sunshine Products? Shares of NATR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Nature's Sunshine Products' stock price today? One share of NATR stock can currently be purchased for approximately $10.99. How big of a company is Nature's Sunshine Products? Nature's Sunshine Products has a market capitalization of $214.43 million and generates $362.21 million in revenue each year. Nature's Sunshine Products employs 905 workers across the globe. What is Nature's Sunshine Products' official website? The official website for Nature's Sunshine Products is www.naturessunshine.com. How can I contact Nature's Sunshine Products? Nature's Sunshine Products' mailing address is 2901 WEST BLUEGRASS BOULEVARD SUITE 100, LEHI UT, 84043. The company can be reached via phone at 801-341-7900 or via email at [email protected] This page was last updated on 8/15/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
